As ROS and OS were demonstrated to have a strong effect on the expression of VEGF/VEGFR2, we performed immunohistochemical staining against NRF2 and AKR1C3 to prove the occurrence of OS in the tumor tissue (Figure S4) [13,25]. The gene discussed is KDR; the disease is neoplasm.